GlassScriptPhysician profile
Roshan T Melvani
NPI 1598184475
$42,120.04
in general payments reported to CMS, 2019-2025
25 companies · $1,425 in 2025
The $1,425 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $11K · 2021: $13K · 2022: $14K · 2023: $602 · 2024: $1,962 · 2025: $1,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,289 · Food and Beverage: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,289.09 |
| Food and Beverage | $1,699.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $17,145.40 | 2020-2024 | Djo Surgical |
| Smith+Nephew, INC. | $10,316.52 | 2020-2023 | Pico 14 |
| Arthrex, INC. | $5,704.23 | 2021-2024 | |
| Empire Medical, INC | $3,600.00 | 2021-2022 | |
| Mvp Orthopedics INC | $1,200.00 | 2021 | |
| Stryker Corporation | $1,091.68 | 2020-2024 | Iconix |
| Medacta USA, INC. | $788.35 | 2025 | Gmk Sphere |
| Medical Device Business Services, INC. | $486.94 | 2020-2021 | |
| Amgen INC. | $266.88 | 2022-2025 | Evenity, Tavneos, Prolia |
| Depuy Synthes Sales INC. | $258.85 | 2021 | |
| Glaxosmithkline, LLC. | $233.62 | 2023-2025 | Benlysta |
| Paragon 28, INC. | $216.20 | 2025 | Portfolio |
| Exactech, INC. | $189.29 | 2021 | |
| Lilly USA, LLC | $144.89 | 2024-2025 | Taltz |
| Ucb, INC. | $111.92 | 2024-2025 | Bimzelx, Cimzia |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $95.95 | 2019 | |
| Dexcom, INC. | $46.93 | 2023-2024 | Dexcom G6 Transmitter |
| Zimmer Biomet Holdings, INC. | $41.98 | 2025 | Juggerknotless Soft Anchor |
| Integra Lifesciences Corporation | $35.26 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $29.29 | 2025 | Caplyta |
| Mallinckrodt Hospital Products INC. | $29.12 | 2024 | Acthar |
| Ethicon US, LLC | $26.49 | 2022 | |
| Abbvie INC. | $25.15 | 2023 | |
| Radius Health, INC. | $19.59 | 2025 | |
| Linvatec Corporation | $15.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshan Melvani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.